Tag Archives: NASDAQ:ATEC

Canaccord Genuity Believes Alphatec Holdings (NASDAQ: ATEC) Won’t Stop Here

Canaccord Genuity analyst Kyle Rose maintained a Buy rating on Alphatec Holdings (ATEC – Research Report) yesterday and set a price target of $16.00. The company’s shares closed last Tuesday at $13.73, close to its 52-week high of $14.97. According

Analysts Are Bullish on Top Healthcare Stocks: Alphatec Holdings (ATEC), Galmed Pharmaceuticals (GLMD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alphatec Holdings (ATEC – Research Report), Galmed Pharmaceuticals (GLMD – Research Report) and Daré Bioscience (DARE – Research Report) with bullish sentiments.

Canaccord Genuity Maintains a Buy Rating on Alphatec Holdings (ATEC)

Canaccord Genuity analyst Kyle Rose maintained a Buy rating on Alphatec Holdings (ATEC – Research Report) yesterday and set a price target of $9.00. The company’s shares closed last Wednesday at $5.89. According to TipRanks.com, Rose is a 4-star analyst

Alphatec Holdings (ATEC) Gets a Buy Rating from Canaccord Genuity

In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Alphatec Holdings (ATEC – Research Report), with a price target of $9.00. The company’s shares closed last Thursday at $6.11. According to TipRanks.com, Rose is

H.C. Wainwright Reiterates a Buy Rating on Alphatec Holdings (ATEC)

In a report issued on April 9, Sean Lee CFA from H.C. Wainwright reiterated a Buy rating on Alphatec Holdings (ATEC – Research Report), with a price target of $7.50. The company’s shares closed last Thursday at $3.94. Alphatec Holdings

Analysts’ Top Healthcare Picks: Alphatec Holdings (ATEC), Karyopharm Therapeutics (KPTI)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alphatec Holdings (ATEC – Research Report) and Karyopharm Therapeutics (KPTI – Research Report) with bullish sentiments. Alphatec Holdings (ATEC) H.C. Wainwright analyst